Ankyron®

Bettin L., et al. (2026). “A novel CD69 binding ankyrin repeat protein (Ankyron®) enables detection of early activated and antigen-specific T cells in pigs.” 01 June 2026, PREPRINT (Version 1) available at Research Square. https://doi.org/10.21203/rs.3.rs-9722577/v1

Hollinghurst P., et al. (2025). “Mosquito NF-κB-mediated innate immunity exerts arbovirus-specific antiviral effects at multiple stages of the viral life cycle.” bioRxiv 2025.11.06.687020. https://doi.org/10.1101/2025.11.06.687020

Hyslop S, et al. (2025). “CD7 regulates the persistence of terminally exhausted CD8+ T cells during chronic infection.” Cell Reports, 2025; 44. https://doi.org/10.1016/j.celrep.2025.116316

Park, YJ., et al. (2024). “Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 Variants.” AAPS J 27, 58 (2025). https://doi.org/10.1208/s12248-025-01043-8

Noble A., et al. (2024). “Development of bovine IgG3-specific assays using a novel recombinant single-domain binding
reagent.” Veterinary Immunology and Immunopathology. https://doi.org/10.1016/j.vetimm.2024.110852

Schmuckli-Maurer, J., et al. (2024) “Plasmodium berghei liver stage parasites exploit host GABARAP proteins for TFEB activation.” Commun Biol 7, 1554 (2024). https://doi.org/10.1038/s42003-024-07242-x